About
Mo Qatanani, Ph.D. is a biotech R&D executive and scientist serving as Chief Scientific Officer of Scholar Rock. Before that, he was Vice President and Head of Research at Dyne Therapeutics and previously held drug discovery leadership roles at Alexion, Synageva, and Merck. His training includes a Ph.D. in molecular and human genetics from Baylor College of Medicine and postdoctoral work at the University of Pennsylvania School of Medicine.
Areas of interest
biotechdrug discoverytranslational researchrare diseaseneuromuscular diseasemuscle diseasesgeneticsobesity therapeutics